Naziv |
Akcije |
(KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Ivić, Marija ; Fazlić Džankić, Amina ; Jonjić, Željko ; Mitrović, Zdravko ; Prka, Željko ; Piršić, Mario ; Jakšić, Ozren ; Gaćina, Petar et al.
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients // Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82. doi: 10.1007/s00508-021-01850-x |
|
Rončević, Pavle ; Mikulić, Mirta ; Prka, Željko ; Duraković, Nadira ; Ostojić, Alen ; Radić-Krišto, Delfa ; Desnica, Lana ; Perić, Zinaida ; Čaržavec, Dubravka ; Sertić, Dubravka et al.
Smjernice za liječenje bolesnika s novodijagnosticiranom akutnom mijeloičnom leukemijom koji nisu podobni za liječenje intenzivnim oblicima liječenja // Bilten Krohema, 13 (2021), 2; 30-31 |
|
Pejsa, Vlatko ; Lucijanic, Marko ; Vrkljan Vuk, Anamarija ; Stoos-Veic, Tajana ; Jaksic, Ozren ; Jonjic, Željko ; Pirsic, Mario ; Prka, Željko ; Ivic, Marija ; Fazlic Dzankic, Amina et al.
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia // Leukemia & lymphoma, 61 (2020), 4; 934-939. doi: 10.1080/10428194.2019.1702182 |
|
Lucijanić, Marko ; Mitrović, Zdravko ; Čičić, David ; Prka, Željko ; Pejša, Vlatko ; Livun, Ana ; Štoos‑Veić, Tajana ; Romić, Željko ; Živković, Marcela ; Lucijanić, Iva et al.
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis // International journal of hematology, 107 (2018), 2; 166-172. doi: 10.1007/s12185-017-2348-4 |
|
Lucijanic, Marko ; Prka, Zeljko ; Jaksic, Ozren ; Mitrovic, Zdravko ; Vrkljan, Anamarija ; Pejsa, Vlatko
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality // American journal of hematology, 94 (2018), 2; E42-E43. doi: 10.1002/ajh.25340 |
|
Pejsa, Vlatko ; Lucijanic, Marko ; Jonjic, Zeljko ; Prka, Zeljko ; Vukorepa, Gorana
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia // Annals of hematology, 98 (2018), 6; 1509-1510. doi: 10.1007/s00277-018-3552-x |
|
Lucijanic, Marko ; Prka, Zeljko ; Pejsa, Vlatko ; Stoos-Veic, Tajana ; Lucijanic, Jelena ; Kusec, Rajko
Prognostic implications of low transferrin saturation in patients with primary myelofibrosis // Leukemia research, 66 (2018), 89-95. doi: 10.1016/j.leukres.2018.01.017 |
|
Štoos-Veić, Tajana ; Aralica, Gorana ; Tomasović- Lončarić, Čedna ; Lucijanić, Marko ; Prka, Željko ; Mitrović, Zdravko ; Livun, Ana ; Novak, Nina Petra ; Škoro, Marija ; Kušec, Rajko
Morfološki pokazatelji mutacijskog statusa bolesnika s esencijalnom trombocitemijom // LIJEČ VJESN 2017 ; 139 (suppl 2):45-45. 2017. str. 45-45 |
|
Pejša, Vlatko ; Prka, Željko ; Lucijanić, Marko ; Mitrović, Zdravko ; Piršić, Mario ; Jakšić, Ozren ; Ajduković, Radmila ; Kušec, Rajko
Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients // Croatian medical journal, 58 (2017), 1; 40-48. doi: 10.3325/cmj.2017.58.40 |
|